Telehealth collaborative care program for lung cancer-related anxiety and depression
Official title: Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study
Run by Abramson Cancer Center at Penn Medicine · NCT07102147 · Data updated 2026-11-12
This project tests whether a more intensive 'high-touch' outreach approach gets more people with lung cancer who have anxiety or depression to join a telehealth collaborative care program than standard outreach.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Abramson Cancer Center at Penn Medicine Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | August 18, 2025 |
| Main results expected | March 31, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT07102147 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) receiving lung cancer treatment or survivorship care at Penn Medicine Thoracic Oncology who are referred for collaborative care for depression or anxiety and are not already in external psychotherapy are ideal candidates.
✕Probably not a fit
Patients already receiving psychotherapy outside Penn, or those with significant untreated medical or psychiatric conditions (for example, active suicidal ideation or psychosis) may not benefit from or be eligible for this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional trial randomizes patients treated at Penn Medicine Thoracic Oncology to receive either a high-touch outreach strategy or standard outreach to invite them into a telehealth-delivered collaborative care model (CoCM) for depression and/or anxiety. The primary outcome is program reach (how many referred patients enroll and engage), and secondary outcomes include implementation measures and clinical effectiveness outcomes for mental health symptoms. Participants are adults referred to Penn's CoCM program who are not already receiving external psychotherapy, with exclusion for significant untreated medical or psychiatric comorbidities. The project builds on prior evidence that CoCM benefits patients with cancer while specifically testing whether outreach intensity increases telehealth program uptake.
Why it matters
Potential benefit: If successful, the approach could increase enrollment in effective telehealth mental health care for people with lung cancer, improving access and anxiety/depression outcomes.
How similar studies have gone: Collaborative care models have shown benefit for depression and anxiety in cancer and general populations, but using a high-touch outreach strategy to boost telehealth CoCM enrollment is a newer, pilot-level approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Are aged 18 years or older. * Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care. * Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services. Exclusion Criteria: * Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC). * Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.
Where it's running
-
Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Alexandria Muench, PsyD — University of Pennsylvania
- Study coordinator: Jennifer Steltz, MRA
- Email: jennifer.steltz@pennmedicine.upenn.edu
- Phone: 215-573-2593
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting lung cancer screening for patients seen in the emergency department
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
-
Personalized music using the ISO principle to reduce stress, anxiety, and depression.
This project tests whether personalized playlists that gradually change musical mood (the ISO principle) can help adults experiencing work-, family-, or other-related stress, anxiety, or depression.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.